Janux Therapeutics, Inc.JANXNASDAQ

52-Week Range12-35

12.12Current 14.1635.34

Want to monitor JANX?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

Revenue Growth

No description available.

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

Transaction in Own Shares

China's record oil output reaches limits of what's possible

Novartis to buy breast cancer drug candidate from Synnovation

Flex LNG - Notice of Annual General Meeting 2026

Alibaba workforce shrinks 34% in 2025 as Chinese tech giant doubles down on AI

Geely: Positive On Profit Surge And Favorable Prospects

KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Paysafe Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PSFE

BellRing Brands, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BRBR

Novartis to Acquire Synnovation Therapeutics' Pan-Mutant Selective PI3Kα Inhibitor Program

Should You Buy Lockheed Martin Stock Right Now?

Tripadvisor: Activist Pressure Supports Our Upside Outlook

Standard Chartered, BSI lose bid to join cases in Singapore winding up firms with assets linked to 1MDB

Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline

Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.

WELL Health Technologies Corp. (WELL:CA) Q4 2025 Earnings Call Transcript

1 Dividend ETF That Could Turn $500 Monthly Into a $725,000 Portfolio That Pays $21,750 Annually

Japan may stockpile US oil domestically, PM says

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

Oil Falls, Asian Equities Mixed Amid Easing Supply-Disruption Concerns

About